Genus Plc is a leading biotechnology company in the United Kingdom, specializing in animal genetics for agriculture. By harnessing advanced scientific methods, Genus breeds and supplies premium genes of pigs and bulls to enhance the profitability of its clients. The company's products, including boars and sows for the porcine market, and bull semen for dairy and beef markets, are specifically selected for characteristics such as feed-efficient growth and leaner meat. Genus also provides embryos through its subsidiary IVB. With an ESG risk rating score of 28.1, Genus PLC is recognized as a medium-risk company in the Pharmaceuticals industry.